Fennec Pharmaceuticals (FENC) Receivables - Net (2022 - 2025)

Fennec Pharmaceuticals' Receivables - Net history runs 4 years deep, the most recent figure standing at $23.2 million for Q4 2025.

• Quarterly Receivables - Net rose 80.23% year-over-year to $23.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.2 million (up 80.23% YoY) and the FY2025 annual result came in at $23.2 million, up 80.23% from the prior year.
• Receivables - Net was $23.2 million for Q4 2025 at Fennec Pharmaceuticals, up from $19.3 million in the prior quarter.
• Across five years, Receivables - Net topped out at $23.2 million in Q4 2025 and bottomed at $1.5 million in Q4 2022.
• A 4-year average of $11.0 million and a median of $12.3 million in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2024 — Receivables - Net soared 510.46% — and 2025, when it surged 42.15%.
• Fennec Pharmaceuticals' Receivables - Net stood at $1.5 million in 2022, then jumped by 470.49% to $8.8 million in 2023, then soared by 46.18% to $12.9 million in 2024, then jumped by 80.23% to $23.2 million in 2025.
• Business Quant data shows FENC's Receivables - Net at $23.2 million in Q4 2025, $19.3 million in Q3 2025, and $17.5 million in Q2 2025.